» Articles » PMID: 36222707

Persistent Borrelia Burgdorferi Infection After Antibiotic Treatment: Systematic Overview and Appraisal of the Current Evidence from Experimental Animal Models

Overview
Specialty Microbiology
Date 2022 Oct 12
PMID 36222707
Authors
Affiliations
Soon will be listed here.
Abstract

Lyme borreliosis is caused by spirochetes belonging to the Borrelia burgdorferi group, which are transmitted by tick species living in the temperate climate zones of the Northern Hemisphere. The clinical manifestations of Lyme borreliosis are diverse and treated with oral or intravenous antibiotics. In some patients, long-lasting and debilitating symptoms can persist after the recommended antibiotic treatment. The etiology of such persisting symptoms is under debate, and one hypothesis entails persistent infection by a subset of spirochetes after antibiotic therapy. Here, we review and appraise the experimental evidence from animal studies on the persistence of B. burgdorferi sensu lato infection after antibiotic treatment, focusing on the antimicrobial agents doxycycline and ceftriaxone. Our review indicates that some animal studies found sporadic positive cultures after antibiotic treatment. However, this culture positivity often seemed to be related to inadequate antibiotic treatment, and the few positive cultures in some studies could not be reproduced in other studies. Overall, current results from animal studies provide insufficient evidence for the persistence of viable and infectious spirochetes after adequate antibiotic treatment. Borrelial nucleic acids, on the contrary, were frequently detected in these animal studies and may thus persist after antibiotic treatment. We put forward that research into the pathogenesis of persisting complaints after antibiotic treatment for Lyme borreliosis in humans should be a top priority, but future studies should most definitely also focus on explanations other than persistent B. burgdorferi sensu lato infection after antibiotic treatment.

Citing Articles

Unguarded liabilities: complex amino acid dependence exposes unique avenues of inhibition.

Holly K, Kataria A, Flaherty D, Groshong A Front Antibiot. 2025; 3():1395425.

PMID: 39816271 PMC: 11732028. DOI: 10.3389/frabi.2024.1395425.


Role of Dual Specificity Phosphatase 1 (DUSP1) in influencing inflammatory pathways in macrophages modulated by lipoproteins.

Kumaresan V, Hung C, Hermann B, Seshu J bioRxiv. 2024; .

PMID: 39605372 PMC: 11601599. DOI: 10.1101/2024.11.20.624562.


PCR Detection of spp. and spp. DNA in Dry Blood Spot Samples from Human Patients.

Clark K, Hartman S Pathogens. 2024; 13(9).

PMID: 39338918 PMC: 11435347. DOI: 10.3390/pathogens13090727.


Hitchhiker's Guide to .

Bourgeois J, Hu L J Bacteriol. 2024; 206(9):e0011624.

PMID: 39140751 PMC: 11411949. DOI: 10.1128/jb.00116-24.

References
1.
Hodzic E, Imai D, Escobar E . Generality of Post-Antimicrobial Treatment Persistence of Strains N40 and B31 in Genetically Susceptible and Resistant Mouse Strains. Infect Immun. 2019; 87(10). PMC: 6759297. DOI: 10.1128/IAI.00442-19. View

2.
Feng J, Li T, Yee R, Yuan Y, Bai C, Cai M . Stationary phase persister/biofilm microcolony of Borrelia burgdorferi causes more severe disease in a mouse model of Lyme arthritis: implications for understanding persistence, Post-treatment Lyme Disease Syndrome (PTLDS), and treatment failure. Discov Med. 2019; 27(148):125-138. View

3.
Morroy G, Keijmel S, Delsing C, Bleijenberg G, Langendam M, Timen A . Fatigue following Acute Q-Fever: A Systematic Literature Review. PLoS One. 2016; 11(5):e0155884. PMC: 4880326. DOI: 10.1371/journal.pone.0155884. View

4.
Wagner B, Johnson J, Garcia-Tapia D, Honsberger N, King V, Strietzel C . Comparison of effectiveness of cefovecin, doxycycline, and amoxicillin for the treatment of experimentally induced early Lyme borreliosis in dogs. BMC Vet Res. 2015; 11:163. PMC: 4513938. DOI: 10.1186/s12917-015-0475-9. View

5.
Summers B, Straubinger A, Jacobson R, Chang Y, Appel M, Straubinger R . Histopathological studies of experimental lyme disease in the dog. J Comp Pathol. 2005; 133(1):1-13. DOI: 10.1016/j.jcpa.2004.11.006. View